1
Nutrition starts with diet
A varied, balanced diet remains the foundation of daily nutrition.
The Science
Eye nutrition, explained clearly.
ORAVU brings 15 targeted nutrients together in one transparent daily formula, led by lutein, zeaxanthin and meso-zeaxanthin. Explore what is included, how the formula is structured and the published research relevant to its ingredients.
Every active amount disclosed. Scientific references linked. No proprietary blend.
The specialist carotenoid core
20 mg
Lutein
4 mg
Zeaxanthin
2 mg
Meso-Zeaxanthin
15
targeted nutrients
2
softgels
1×
daily
Why Eye Nutrition
Your eyes need nutrition, too.
Like the rest of the body, the eyes rely on nutrients obtained through the diet. Eye nutrition brings selected carotenoids, vitamins, minerals, fatty acids, botanical extracts and other compounds into a defined daily routine.
ORAVU provides this specialist approach in two softgels taken once daily. It is a nutritional supplement—not an eye drop, medicine or replacement for professional eye care.
2
Specialist eye nutrition
Eye-focused supplements bring selected nutrients together in defined daily amounts.
3
A consistent routine
ORAVU provides its complete daily serving in two softgels, taken once a day.
Our Evidence Approach
Not all scientific evidence means the same thing.
1
Ingredient evidence
Research on an individual nutrient at a specific form, dose, duration and population.
2
Formula evidence
Research on a defined combination of ingredients and dosages.
3
Finished-product evidence
Research conducted on the complete finished product itself.
The publications linked on this page relate to individual ingredients or defined nutrient combinations. They should not be read as clinical trials on the finished ORAVU formula.
The Specialist Core
Three macular carotenoids at the centre of the formula.
Lutein, zeaxanthin and meso-zeaxanthin are the three carotenoids concentrated in the macula, the central region of the retina involved in detailed vision. Together, they form ORAVU's strongest specialist eye-nutrition foundation.
20 mg
Lutein
A recognised macular carotenoid with human randomized-trial research at studied doses.
Read the lutein study4 mg
Zeaxanthin
A macular carotenoid included alongside lutein as part of ORAVU's central carotenoid architecture.
Read the lutein and zeaxanthin study2 mg
Meso-Zeaxanthin
The third macular carotenoid, included to complete ORAVU's three-carotenoid profile.
Read the three-carotenoid trial
Start Rebuilding The Filter.
Macular Pigment Rebuilds Over 8 to 12 Weeks. The 3 Bottles Bundle Is A Complete 90-Day Course.
✓ SELECTED
30-Day Supply
1 Bottle
30 days
AED 199
AED 6.63 a day
Free UAE delivery
✓ SELECTED
60-Day Supply
2 Bottles
60 days
AED 376
AED 6.27 a day
Free UAE delivery
✓ SELECTED
Most popular
90-Day Supply
3 Bottles
90 days-full course
AED 531
AED 5.90 a day
Free UAE delivery
Full Macular Support.
Free Next-Day UAE Delivery.
Pay In 4 With Tabby, Interest-Free
The Complete Formula
15 targeted nutrients, organised by nutrient family.
ORAVU presents its formula as a structured eye-nutrition system rather than treating ingredient count as proof.
Macular carotenoids
The specialist core.
- Lutein
- Zeaxanthin
- Meso-Zeaxanthin
Additional carotenoid and flavonoid compounds
- Astaxanthin
- Luteolin
Vitamins and minerals
- Vitamin C
- Vitamin E
- Zinc
- Copper
Fatty acids and additional compounds
- Fish Oil providing EPA and DHA
- Alpha-Lipoic Acid
- Taurine
- Hyaluronic Acid
Botanical extracts
- Bilberry Extract
- Ginkgo Biloba
Full Transparency
Every active amount, clearly disclosed.
Two softgels provide one complete daily serving. ORAVU does not use a proprietary blend: every active ingredient and its daily amount are shown individually.
| Active ingredient | Amount per daily serving | Selected evidence type | Research |
|---|---|---|---|
| Lutein | 20 mg | Human RCT | View publication |
| Zeaxanthin | 4 mg | Human RCT | View publication |
| Meso-Zeaxanthin | 2 mg | Human clinical trial | View publication |
| Astaxanthin | 4 mg | Human RCT | View publication |
| Vitamin C | 150 mg | Human clinical trial | View publication |
| Vitamin E | 30 mg | Human clinical trial | View publication |
| Alpha-Lipoic Acid | 50 mg | Preclinical retinal study | View publication |
| Fish Oil | 250 mg | Human clinical trial | View publication |
| — providing EPA | 45 mg | Human clinical trial | View publication |
| — providing DHA | 30 mg | Human clinical trial | View publication |
| Zinc | 15 mg | Human clinical trial | View publication |
| Copper | 2 mg | Human clinical trial | View publication |
| Bilberry Extract | 50 mg | Human RCT | View publication |
| Ginkgo Biloba | 40 mg | Systematic review | View publication |
| Taurine | 75 mg | Scientific review | View publication |
| Luteolin | 50 mg | Preclinical cell study | View publication |
| Hyaluronic Acid | 120 mg | Pilot human study | View publication |
Lutein
20 mgHuman RCT
View publicationZeaxanthin
4 mgHuman RCT
View publicationMeso-Zeaxanthin
2 mgHuman clinical trial
View publicationAstaxanthin
4 mgHuman RCT
View publicationVitamin C
150 mgHuman clinical trial
View publicationVitamin E
30 mgHuman clinical trial
View publicationAlpha-Lipoic Acid
50 mgPreclinical retinal study
View publicationFish Oil
250 mgHuman clinical trial
View publication— providing EPA
45 mgHuman clinical trial
View publication— providing DHA
30 mgHuman clinical trial
View publicationZinc
15 mgHuman clinical trial
View publicationCopper
2 mgHuman clinical trial
View publicationBilberry Extract
50 mgHuman RCT
View publicationGinkgo Biloba
40 mgSystematic review
View publicationTaurine
75 mgScientific review
View publicationLuteolin
50 mgPreclinical cell study
View publicationHyaluronic Acid
120 mgPilot human study
View publicationResearch links are selected publications relevant to individual ingredients or defined combinations. Study forms, doses, populations and outcomes may differ from ORAVU. The linked publications do not constitute finished-product clinical evidence.
Science Without Shortcuts
Research guides the formula—not the marketing language.
The carotenoid core leads
Lutein, zeaxanthin and meso-zeaxanthin provide ORAVU's clearest specialist eye-nutrition foundation.
Dose and context matter
Ingredient form, daily dose, studied population, duration and measured outcome all shape how research should be interpreted.
Transparency comes first
Every active amount is disclosed so the ORAVU formula can be evaluated as it is—not as a hidden blend.
Why ORAVU Exists
Created around modern screen-heavy Gulf life.
Modern Gulf routines often mean long hours on phones, laptops and other screens, together with extended time in air-conditioned indoor spaces. ORAVU was created around that daily context, bringing specialist eye nutrition into one transparent routine.
Regional and UAE publications help explain the lifestyle context behind ORAVU. They do not test the product or establish that ORAVU treats digital eye strain or dry-eye disease.
Screen-heavy routines
Phones, computers, tablets and game consoles.
Air-conditioned spaces
Offices, homes, cars and indoor environments.
One daily routine
15 targeted nutrients in two softgels, taken once daily.
Explore the Evidence
Read the research behind the formula and its context.
Selected publications are summarized in plain language, with study design and limitations shown alongside their relevance to ORAVU.
Macular carotenoids
Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease
- What was studied
- The chemistry, physiology and clinical research surrounding all three macular carotenoids.
- Why it is relevant
- Explains why lutein, zeaxanthin and meso-zeaxanthin are concentrated in the macula and central to specialist eye nutrition.
- Limitations
- A review of the wider evidence base; it is not a study of ORAVU.
Macular carotenoids
Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density
- What was studied
- Randomized trials involving healthy participants and people with age-related macular degeneration.
- Why it is relevant
- Found supplementation with macular xanthophyll carotenoids was associated with higher macular pigment optical density.
- Limitations
- Included different formulations, doses and populations; it is not evidence on the finished ORAVU formula.
Macular carotenoids
Enrichment of Macular Pigment Enhances Contrast Sensitivity in Subjects Free of Retinal Disease: CREST Report 1
- What was studied
- 105 adults with low macular pigment received lutein, zeaxanthin and meso-zeaxanthin or placebo for 12 months.
- Why it is relevant
- Provides human clinical evidence for the three-carotenoid combination that anchors ORAVU's specialist formula.
- Limitations
- The study used a different carotenoid ratio and did not evaluate the complete ORAVU formula.
Screen-use research
The effects of lutein/zeaxanthin on eye health, eye strain, sleep quality, and attention in high electronic screen users
- What was studied
- 70 adults using electronic screens for more than six hours daily received 10 mg lutein plus 2 mg zeaxanthin isomers or placebo for six months.
- Why it is relevant
- Directly relevant to screen-heavy adults and to two of ORAVU's core carotenoids.
- Limitations
- Some objective eye assessments improved, while self-reported measures and contrast sensitivity did not differ between groups.
Supporting formula
Effects of diet containing astaxanthin on visual function in healthy individuals
- What was studied
- 60 healthy adults received 9 mg astaxanthin or placebo for six weeks.
- Why it is relevant
- Human research relevant to astaxanthin as an additional carotenoid in the ORAVU formula.
- Limitations
- The studied dose was higher than ORAVU's 4 mg, and significant findings were limited to selected outcomes and subgroups.
Supporting formula
Bilberry extract supplementation for preventing eye fatigue in video display terminal workers
- What was studied
- Office workers received 480 mg bilberry extract or placebo daily for eight weeks.
- Why it is relevant
- Examined bilberry in a screen-use context using objective and self-reported measures.
- Limitations
- The studied dose was substantially higher than the 50 mg included in ORAVU.
UAE & Gulf context
Digital eye health and behavioral determinants of screen use among university students in the UAE
- What was studied
- 463 university students across three universities in Ras Al Khaimah.
- Why it is relevant
- Documents extensive daily screen use and frequently reported eye-related symptoms in a UAE student sample.
- Limitations
- A university sample; it does not represent all UAE adults and did not evaluate ORAVU or any supplement.
UAE & Gulf context
The prevalence, severity, and risk factors for dry eye disease in Dubai
- What was studied
- 452 participants from university and hospital communities in Dubai.
- Why it is relevant
- Found high daily screen time above six hours was associated with dry-eye findings in the surveyed sample.
- Limitations
- Survey-based and not nationally representative; it provides lifestyle context, not product-efficacy evidence.
UAE & Gulf context
Dry Eye Disease in the Middle East and Northern Africa: A Position Paper on the Current State and Unmet Needs
- What was studied
- Consensus discussions among ophthalmologists on climatic, lifestyle and clinical factors relevant to the MENA region.
- Why it is relevant
- Supports the regional context behind ORAVU's focus on modern Gulf routines and environments.
- Limitations
- A position paper on dry-eye care; it did not test ORAVU or an oral eye-nutrition formula.
Quality & Testing
Science explains why the ingredients are here. Quality shows how ORAVU is made and checked.
Explore ORAVU's manufacturing standards, certifications, testing process and product traceability.
ORAVU Daily Eye Nutrition
Transparent formula. Clear research. One daily routine.
15 targeted nutrients. 2 softgels. Once daily.
Daily eye nutrition created for screen-heavy Gulf life.
30
day supply
2
softgels
1×
daily